₹ 11.096
NAV (Sep 29)
Investment Duration5 years
0
Total Investment0
Wealth Gained0
Total Corpus Created (₹)
With CAGR of 11.25 % in 5 years₹ 11.096
NAV (Sep 29)
Last 1Y | 19.4% |
Last 3Y | NA |
Last 5Y | NA |
Last 10Y | NA |
Since Inception | 5.7% |
6 Month CAGR | 24.4% |
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However,there can be no assurance that the investment objective of the scheme would be achieved.
Expense Ratio | 2.34 |
Launched (2y ago) | Nov 11, 2021 |
AUM in Crores | 137.953 |
ISIN | INF00XX01BL5 |
Lock-in | No Lock-in |
Benchmark | Nifty Healthcare TR INR |
SIP Minimum | 1000 |
Lumpsum Min. | 5000 |
Standard Deviation (3yr) | 0 |
Standard Deviation (5yr) | 0 |
Beta (3yr) | 0 |
Beta (5yr) | 0 |
Sharpe Ratio (3yr) | 0 |
Sharpe Ratio (5yr) | 0 |
YTM | 0 |
of
for
with step up of
Asset | Returns | Total Corpus | Gains | CAGR |
---|---|---|---|---|
ITI Pharma and Healthcare Fund (Growth) | NaN | NaN | % | |
EPF | 9,00,761 | 1,68,149 | 8.50% | |
Property | 8,67,662 | 1,35,050 | 7.00% | |
PPF | 8,69,819 | 1,37,207 | 7.10% | |
Bank FD | 8,46,471 | 1,13,859 | 6.00% | |
Gold | 8,46,471 | 1,13,859 | 6.00% | |
Savings Bank | 8,25,950 | 93,338 | 5.00% |
Disclaimer: Products compared like fixed deposits may provide fixed guaranteed returns. Mutual Funds investments are subject to market risk, read all scheme related documents carefully before investing. Past performance is not an indicator of future returns.
sun pharmaceuticals industries ltd
15.9%cipla ltd shs dematerialised
7.3%dr reddy's laboratories ltd
5.7%max healthcare institute ltd ordinary shares
5.5%lupin ltd
5.3%healthcare
94.2%basic materials
3.3%Fund Name | Fund Size | Outperformance Consistency |
---|---|---|
₹ 11,862 cr | ||
₹ 17,630 cr | ||
₹ 11,197 cr | ||
₹ 10,089 cr | ||
₹ 9,392 cr |
ITI Asset Management Limited
Fund Name | Scripbox Opinion | Till Date CAGR | |
---|---|---|---|
- | 4.7% | ||
3.4% | 3.4% | ||
18.9% | 13.7% | ||
- | 9.9% | ||
- | 5.7% |
ITI Pharma and Healthcare Fund (G) is a Sectoral/ Thematic Equity fund and has delivered an annualised return of 5.7% over a period of 1 years. The fund is managed by ITI Asset Management Limited. The fund managers are Dhimant Shah, Rohan Korde, Tanay Gabhawala.
Nav of ITI Pharma and Healthcare Fund (G) as of 9/29/2023 is ₹11.10 with the total AUM as of 10/3/2023 is ₹137.953. With Scripbox you can compare and check the latest nav for all mutual funds in India. ITI Pharma and Healthcare Fund (G) was launched on Nov 11, 2021. The category risk of the fund is Very High Risk.
The minimum SIP amount for ITI Pharma and Healthcare Fund (G) is ₹1000 and you can increase this in multiples of ₹100. In case you want to invest a lump sum, the minimum amount to be invested is ₹5000. Check your estimated returns on mutual funds by using sip calculator.
ITI Pharma and Healthcare Fund (G) is meant for investors with a minimum investment horizon of 5-7 years. Due to the asset class nature, expect volatility in your investments over the short term. The fund is benchmarked to Nifty Healthcare TR INR.
ITI Pharma and Healthcare Fund (G) is rated as a 0 fund in Equity and delivered 19.4% returns in the last 1 year. Scripbox provides a compare mutual funds research tool to view a detailed comparison with ITI Pharma and Healthcare Fund (G).
What is ITI Pharma and Healthcare Fund (G)?
How to invest in ITI Pharma and Healthcare Fund (G)?
You can invest in ITI Pharma and Healthcare Fund (G) through AMC, intermediaries, brokers or platforms like Scripbox. To learn step by step process visit how to invest in mutual funds?
What is the minimum sip amount of ITI Pharma and Healthcare Fund (G)?
The minimum sip amount for ITI Pharma and Healthcare Fund (G) is ₹1000. You can invest in multiples of ₹5000.
Is ITI Pharma and Healthcare Fund (G) good to invest in?
As per Scripbox experts, ITI Pharma and Healthcare Fund (G) is a Not Reviewed Yet fund. You can investITI Pharma and Healthcare Fund (G) fund if its investment objective and risk-o-meter matches your investment goals and risk preferences.
What is the expense ratio of the ITI Pharma and Healthcare Fund (G)?
The expense ratio of the ITI Pharma and Healthcare Fund (G) is 2.34% for regular plan.